Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

ClinicalTrials.gov ID: NCT00012324

Public ClinicalTrials.gov record NCT00012324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 16, 2026, 5:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Controlled Study Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma (HCC) Treated With THYMITAQ to Patients Treated With Doxorubicin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which chemotherapy regimen is more effective for liver cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two different chemotherapy regimens in treating patients who have recurrent or unresectable liver cancer.

Study identification

NCT ID
NCT00012324
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eximias Pharmaceutical
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2000
Primary completion
Not listed
Completion
Oct 31, 2005
Last update posted
Jun 25, 2013

2000 – 2005

United States locations

U.S. sites
38
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
Arizona Clinical Research Center, Incorporated Tucson Arizona 85715
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Tower Cancer Research Foundation Beverly Hills California 90211
Scripps Cancer Center at Scripps Clinic La Jolla California 92037
David and Donna Long Center for Cancer Treatment at Sharp Grossmont Hospital La Mesa California 91942
Veterans Affairs Medical Center - Long Beach Long Beach California 90822
California Pacific Medical Center - Pacific Campus San Francisco California 94115
Olive View - UCLA Medical Center Foundation Sylmar California 91342
California Hematology/Oncology Medical Group Torrance California 90505
Helen F. Graham Cancer Center Newark Delaware 19713
Lombardi Cancer Center at Georgetown University Medical Center Washington D.C. District of Columbia 20007
Florida Cancer Institute - Bayonet Point Hudson Florida 34667
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136
Oncology-Hematology Group of South Florida, P.A. Miami Florida 33176
Ocala Research Institute, Incorporated Ocala Florida 34480
Cancer Research Center of Hawaii Honolulu Hawaii 96813
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611
University of Illinois at Chicago Cancer Center Chicago Illinois 60612
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1009
Louisiana Oncology Associates - Lafayette Lafayette Louisiana 70506
Stanley S. Scott Cancer Center at Louisiana State University Medical Center - New Orleans New Orleans Louisiana 70112
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital Baltimore Maryland 21215
University of Minnesota Cancer Center Minneapolis Minnesota 55455
Saint Louis University Cancer Center St Louis Missouri 63110
Siteman Cancer Center at Barnes-Jewish Hospital St Louis Missouri 63110
UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska 68198-7680
Hackensack University Medical Center Hackensack New Jersey 07601
Veterans Affairs Medical Center - Albuquerque Albuquerque New Mexico 87108
New York Weill Cornell Cancer Center at Cornell University New York New York 10021
Herbert Irving Comprehensive Cancer Center at Columbia University New York New York 10032
SUNY Upstate Medical University Hospital Syracuse New York 13210
Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx New York 10467
New York Medical College Valhalla New York 10595
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44111
Albert Einstein Cancer Center Philadelphia Pennsylvania 19141
Cancer Centers of the Carolinas - Eastside Greenville South Carolina 29615
Medical City Dallas Hospital Dallas Texas 75230
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410-1894

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00012324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2013 · Synced Sep 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00012324 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →